Hadasit Bio Holding Ltd. Share Price TEL AVIV STOCK EXCHANGE
Equities
IL0010954050
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 7.43M 2.01M 743M 159M |
---|---|---|---|---|---|
Net income 2022 | -31M -8.39M -3.1B -665M | Net income 2023 | -29M -7.85M -2.9B -622M | EV / Sales 2022 | - |
Net cash position 2022 | 12.93M 3.5M 1.29B 278M | Net cash position 2023 | 6.46M 1.75M 646M 139M | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.46
x | P/E ratio 2023 |
-0.25
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25% |
Managers | Title | Age | Since |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 19/09/15 |
Tamar Raz
CHM | Chairman | 60 | 17/05/14 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 30/08/15 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 28/07/18 |
Erez Meltzer
BRD | Director/Board Member | 66 | 04/07/16 |
Orit Stav
BRD | Director/Board Member | 53 | 31/10/17 |
1st Jan change | Capi. | |
---|---|---|
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+48.83% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |